Latest News
Imdelltra Imfinzi Approval: When Could First-Line Use Begin?
Amgen and AstraZeneca presented full DeLLphi-305 results at the ESMO Congress in Madrid. The phase 3 trial added Amgen’s Imdelltra (tarlatamab-dlle) to AstraZeneca’s Imfinzi (durvalumab). It cut the risk of death by 58 per cent in extensive-stage small cell lung...
Latest News
Medical AI Is Getting Better. Why Is Diagnosis Getting Harder?
A radiologic study today rarely arrives alone. It comes wrapped in automated detection flags, quantitative lesion scores, an AI-drafted report, historical imaging, EHR clinical notes, and subspecialty consult requests. What it does not come wrapped in is medical AI...
Stellaromics Expands Pyxa Adoption Across the U.S. and Europe
Stellaromics Expands Pyxa® Adoption as Instruments are Installed at Leading Research Institutions Across the U.S. and Europe Icahn School of Medicine at Mount Sinai, CNAG, Karolinska Institutet, and Stanford University will apply 3D spatial multi-omics across...
Freeze-Dried Does Not Mean Pathogen-Free
Once concentrated in commercial manufacturing, freeze-drying has entered home kitchens and small food businesses through countertop equipment. That shift has made freeze-dried food safety a live question for small operators. University of Minnesota Extension describes...
Why AI Governance in Life Sciences Can’t Wait for Regulatory Clarity
The regulatory picture for AI governance in life sciences just got more confusing, not less. In June 2026, the European Union's Digital Omnibus package pushed back the EU AI Act's compliance deadline for stand-alone high-risk AI systems from August 2026 to December...
Join The Future Of Life Sciences Media
In a world overflowing with information, LifeScienceDaily.news stands apart as the dedicated space where life sciences professionals share what’s new, what’s next, and why it matters, all in real time.
Don’t wait for the media to pick up your story. Be the media.
Trending
More News
Weekly News Roundup | 4 May 2026
Life science news 4 May 2026: Eli Lilly's record $19.8 billion quarterly earnings, the FDA's real-time clinical trial revolution and a landmark week for UK regulatory reform define a momentous seven days for global life science. Eli Lilly reported worldwide revenue of...
The Gap Between Precision Medicine and Clinical Reality
Precision medicine is no longer a futuristic concept. Genomic panels, pharmacogenomic testing, advanced biomarker analysis, and individualized risk stratification tools are all available today. Yet for the vast majority of patients walking into a primary care office,...
Clinical Trials Roundup | 1 May 2026
Etavopivat delivers Phase 3 success in sickle cell disease, satralizumab becomes the first positive Phase 3 result in MOGAD, AstraZeneca completes its triple-positive COPD biologic programme, and a busy week for paediatric medicine brings new approvals and data in...
Longevity Biotech: Separating the Science from the Hype
The Billion-Dollar Race to Slow Ageing Billions of dollars are pouring into the idea that ageing is a disease we can treat. The longevity biotech sector attracted $8.49 billion in private investment across 325 deals in 2024, according to Longevity.Technology's Annual...
Sun Pharma’s $11.75bn Organon Deal Reshapes Global Pharma
India's largest pharmaceutical company, Sun Pharmaceutical Industries, has agreed to acquire New Jersey-based Organon & Co. in an all-cash transaction valued at $11.75 billion, marking the largest acquisition ever undertaken by an Indian biopharmaceutical company....
Report Finds Seven in Ten Leaders Bullied by Their Teams
Healthcare organisations invest significantly in psychosocial risk frameworks, governance structures and leadership development. Yet a new international study highlights a type of organisational risk that most of those frameworks are not designed to detect. It is a...
How Traditional Japanese Wisdom can Bridge the Cardiovascular Health Gap
For decades, the global medical community has looked to Japan with a sense of wonder, specifically regarding the Japanese paradox of longevity. Epidemiological data consistently highlights a significant cardiovascular health gap between Japan and Western nations like...
Speech Could be a Key Marker in Neurodegenerative Disease Drug Trials
Speech is rapidly emerging as an important, non-invasive, digital clinical marker in neurodegenerative disease research, according to leading biotech SynaptixBio. The company has facilitated a study run by Australia-based speech analytics company Redenlab, in...
How AI-Driven Research is Reshaping Competitive Intelligence in Pharma
AI developments are happening at breakneck speed, with every sector and industry seeking new opportunities to seize and capitalise upon. AI-driven research is creating a fundamental shift for pharmaceutical competitive intelligence, moving away from a reactive, manual...
A ‘Bariatric-Level’ Obesity Drug Is Coming: Retatrutide and the UK Reality
The pharmaceutical press is having a very loud year. Eli Lilly's investigational triple-agonist retatrutide has produced the kind of phase 2 data that clinicians usually only see in editorials about the future, up to 24.2% mean body-weight reduction at 48 weeks in the...
Trump FDA Drug Approvals: Global Impact
Trump FDA Drug Approvals: How US Regulatory Upheaval Is Reshaping the Global Pharmaceutical Industry The United States Food and Drug Administration has long been regarded as the gold standard of drug regulation. When a medicine receives FDA approval, it carries a...
Most Supplement Companies Skip the RCT
Most Supplement Companies Skip the RCT. Here’s Why the Few That Don’t Often Get It Wrong The industry’s uncomfortable truth The global dietary supplement market is worth hundreds of billions of dollars.[1] Brands make claims about energy, cognition, immunity, and...
Weekly News Roundup | 4 May 2026
Life science news 4 May 2026: Eli Lilly's record $19.8 billion quarterly earnings, the FDA's real-time clinical trial revolution and a landmark week for UK regulatory reform define a momentous seven days for global life science. Eli Lilly reported worldwide revenue of...
The Gap Between Precision Medicine and Clinical Reality
Precision medicine is no longer a futuristic concept. Genomic panels, pharmacogenomic testing, advanced biomarker analysis, and individualized risk stratification tools are all available today. Yet for the vast majority of patients walking into a primary care office,...
Clinical Trials Roundup | 1 May 2026
Etavopivat delivers Phase 3 success in sickle cell disease, satralizumab becomes the first positive Phase 3 result in MOGAD, AstraZeneca completes its triple-positive COPD biologic programme, and a busy week for paediatric medicine brings new approvals and data in...
Longevity Biotech: Separating the Science from the Hype
The Billion-Dollar Race to Slow Ageing Billions of dollars are pouring into the idea that ageing is a disease we can treat. The longevity biotech sector attracted $8.49 billion in private investment across 325 deals in 2024, according to Longevity.Technology's Annual...
Sun Pharma’s $11.75bn Organon Deal Reshapes Global Pharma
India's largest pharmaceutical company, Sun Pharmaceutical Industries, has agreed to acquire New Jersey-based Organon & Co. in an all-cash transaction valued at $11.75 billion, marking the largest acquisition ever undertaken by an Indian biopharmaceutical company....
Report Finds Seven in Ten Leaders Bullied by Their Teams
Healthcare organisations invest significantly in psychosocial risk frameworks, governance structures and leadership development. Yet a new international study highlights a type of organisational risk that most of those frameworks are not designed to detect. It is a...
How Traditional Japanese Wisdom can Bridge the Cardiovascular Health Gap
For decades, the global medical community has looked to Japan with a sense of wonder, specifically regarding the Japanese paradox of longevity. Epidemiological data consistently highlights a significant cardiovascular health gap between Japan and Western nations like...
Speech Could be a Key Marker in Neurodegenerative Disease Drug Trials
Speech is rapidly emerging as an important, non-invasive, digital clinical marker in neurodegenerative disease research, according to leading biotech SynaptixBio. The company has facilitated a study run by Australia-based speech analytics company Redenlab, in...
How AI-Driven Research is Reshaping Competitive Intelligence in Pharma
AI developments are happening at breakneck speed, with every sector and industry seeking new opportunities to seize and capitalise upon. AI-driven research is creating a fundamental shift for pharmaceutical competitive intelligence, moving away from a reactive, manual...
A ‘Bariatric-Level’ Obesity Drug Is Coming: Retatrutide and the UK Reality
The pharmaceutical press is having a very loud year. Eli Lilly's investigational triple-agonist retatrutide has produced the kind of phase 2 data that clinicians usually only see in editorials about the future, up to 24.2% mean body-weight reduction at 48 weeks in the...
Trump FDA Drug Approvals: Global Impact
Trump FDA Drug Approvals: How US Regulatory Upheaval Is Reshaping the Global Pharmaceutical Industry The United States Food and Drug Administration has long been regarded as the gold standard of drug regulation. When a medicine receives FDA approval, it carries a...
Most Supplement Companies Skip the RCT
Most Supplement Companies Skip the RCT. Here’s Why the Few That Don’t Often Get It Wrong The industry’s uncomfortable truth The global dietary supplement market is worth hundreds of billions of dollars.[1] Brands make claims about energy, cognition, immunity, and...
Featured Articles
Further News
Doctor, Patient, Agent: A New Clinical Triad for Medicine
By 6:45 AM, the dashboard is already waiting. A longevity physician sits down with coffee and reads what the monitoring agent assembled overnight: a falling seven-day HRV trend in a patient recovering from a viral illness, a queued statin titration for a...
Physiology: The Missing Layer in Precision Medicine
Precision medicine has been positioned as one of the most promising evolutions in modern healthcare. Gene panels. Liquid biopsies. Microbiome-targeted therapies. Multi-omics integration. The premise is compelling: the more precisely we can characterize biological...
Weekly News Roundup | 27 April 2026
Life science news 27 April 2026: Eli Lilly's $7 billion in vivo CAR-T deal, Trump's psychedelics executive order and a first-ever gene therapy for hearing loss headline a landmark week across global life science. Eli Lilly announced on 20 April its acquisition of...
Life Science Daily News: Join the Community
A Community-Driven Hub for Life Sciences News and Discovery In an era of rapid scientific progress and near-constant breakthroughs, having a reliable, inclusive platform to share and explore life-sciences news is more important than ever. Life Science Daily News...
Clinical Trials Roundup | 24 April 2026
Neurona Therapeutics' rezanecel demonstrates durable seizure reduction past the one-year mark in drug-resistant mesial temporal lobe epilepsy at the AAN Annual Meeting, Gilead Sciences and Arcus Biosciences' TIGIT inhibitor domvanalimab fails its pivotal Phase 3 lung...
AstraZeneca’s $18.5 Billion China Obesity Drug Deal Explained
AstraZeneca China Obesity Drug Deal: A $18.5 Billion Bet on the Future of Weight Management AstraZeneca announced on 30 January 2026, what has quickly become known as the AstraZeneca CSPC obesity deal, a landmark licensing and collaboration agreement with China's CSPC...
Beyond Words: AI, Human-Centered Design, and the Future of Health Literacy
The Evolving Definition of Health Literacy In August 2020, the Centers for Disease Control and Prevention (CDC) updated its definition of health literacy, emphasizing the ability to use health information effectively (CDC). This shift highlights that merely...
The iPS Era is Arriving – Now the Field Must Prove it Can Scale
For years, induced pluripotent stem cells, or iPS cells, have stood for one of the most ambitious ideas in modern medicine - that it may be possible to create replacement human cells on-demand and use them to restore lost function in the body. With 20 years of history...
Boehringer Ingelheim Opens AI Centre in London’s Knowledge Quarter
Boehringer Ingelheim AI Centre London: A New Frontier for Pharmaceutical Research German biopharmaceutical company Boehringer Ingelheim announced on 20 April 2026 the launch of a new centre for artificial intelligence and machine learning in King's Cross, London, as...
Tumor Vasculature has Long Been a Target. Measuring it is the Next Step
Oncology drug development is more mechanistically advanced than ever. Scientists and researchers design therapies to block immune evasion, disrupt tumor metabolism, and rewire the microenvironment. Yet a costly problem remains: many patients who should respond to...
When ADHD and Menopause Overlap
When ADHD and Menopause Overlap: Why Midlife Women Are Still Not Getting the Right Answers Girls and women have historically been overlooked in the ADHD diagnostic process and this is due, in part, to the fact that their symptoms often present differently than they do...
How Rapid Access MRI Can Reshape Diagnostic Pathways
It’s no secret that the National Health Service (NHS) is suffering diagnostic pressure. The British Medical Association (BMA) reports that in November 2024, approximately 1.6 million people in England were waiting for a diagnostic test. That’s double the 0.8...
Further News
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.
Don’t wait for the media to pick up your story. Be the media.
See More Articles
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.